研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年的期刊文章 · 第 35 页
共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-01-24 到 2026-01-19。
按期刊、按主题看 →
SiM Causal Inference · 发表于 2026-01-24,收录于 2026-10-20
Tat-Thang Vo, Nicholas Williams, Richard Liu, Kara E Rudolph, Iván Díaz
摘要
The presence of intermediate confounders, also called recanting witnesses, is a fundamental challenge to the investigation of causal mechanisms in mediation analysis, preventing the identification of natural path‐specific effects. Common alternatives (such as randomizational interventional effects) are problematic because they can take non‐null values even when there is no mediation for any individual in the population. A promising alternative to natural path‐specific effects was outlined in a recent article based on replacing recanting witnesses by draws from their conditional distribution. In this manuscript we formally develop these parameters (which we call recanting twin effects) into a viable alternative to natural effects for mediation analysis in the presence of intermediate confounding. Our contributions include (i) proposing a falsification procedure to test whether the observed data are compatible with intermediate confounding by a given intermediate variable, (ii) showing that recanting twin effects are equal to natural effects at the individual level in the absence of intermediate confounding, (iii) showing that recanting twin effects can be interpreted in agential frameworks such as the recently proposed separable effects , in addition to the non‐agential framework in which they were originally outlined, and (iv) developing non‐parametric efficiency theory including deriving the efficiency bound and non‐parametric efficient estimators that can accommodate high‐dimensional confounders through the use of data‐adaptive estimation methods. We present an application of the methods to evaluate the role of new‐onset anxiety and depressive disorder in explaining the relationship between gabapentin/pregabalin prescription and incident opioid use disorder among Medicaid beneficiaries with chronic pain.
SMMR Nonparametric & Semiparametric Genetics & Omics Econometrics & Economics · 发表于 2026-01-23
Lei Wang, Yang Ni, Irina Gaynanova
摘要
Increasing epidemiologic evidence suggests that the diversity and composition of the gut microbiome can predict infection risk in cancer patients. Infections remain a major cause of morbidity and mortality during chemotherapy. Analyzing microbiome data to identify associations with infection pathogenesis for proactive treatment has become a critical research focus. However, the high-dimensional nature of the data necessitates the use of dimension-reduction methods to facilitate inference and interpretation. Traditional dimension reduction methods, which assume Gaussianity, perform poorly with skewed and zero-inflated microbiome data. To address these challenges, we propose a semiparametric principal component analysis method based on a truncated latent Gaussian copula model that accommodates both skewness and zero inflation. Simulation studies demonstrate that the proposed method outperforms existing approaches by providing more accurate estimates of scores and loadings across various copula transformation settings. We apply our method, along with competing approaches, to gut microbiome data from pediatric patients with acute lymphoblastic leukemia. The principal scores derived from the proposed method reveal the strongest associations between pre-chemotherapy microbiome composition and adverse events during subsequent chemotherapy, offering valuable insights for improving patient outcomes.
JASA Other · 发表于 2026-01-23
Wenhui Li, Xinyu Zhang
摘要
We propose a model averaging method for high-dimensional regression with highly correlated covariates. We use a factor structure to model the covariate dependence, allowing the covariates to be decomposed into two uncorrelated or weakly correlated latent components: common factors and idiosyncratic components. The number of common factors is allowed to diverge. We average estimators from factor-adjusted candidate models with augmented predictors composed of estimated common factors and idiosyncratic components. We prove the asymptotic optimality in the sense of achieving the lowest squared loss and the consistency when correctly specified models exist in the model space. Numerical experiments and a real-data analysis illustrate the promising performance of the proposed method. *(abstract via OpenAlex)*
SiM Other · 发表于 2026-01-23
Marco Ratta, Gaëlle Saint‐Hilary, Valentine Barboux, Mauro Gasparini, Donia Skanji, Pavel Mozgunov
摘要
The urgency of delivering novel, effective treatments against life‐threatening diseases has brought various health authorities to allow for Accelerated Approvals (AAs). AA is the “fast track” program where promising treatments are evaluated based on surrogate (short term) endpoints likely to predict clinical benefit. This allows treatments to get an early approval, subject to providing further evidence of efficacy, for example, on the primary (long term) endpoint. Despite this procedure being quite consolidated, a number of conditionally approved treatments do not obtain full approval (FA), mainly due to lack of correlation between surrogate and primary endpoint. This implies a need to improve the criteria for controlling the risk of AAs for noneffective treatments, while maximizing the chance of AAs for effective ones. We first propose a novel adaptive group sequential design that includes an early dual‐criterion “Accelerated Approval” interim analysis, where efficacy on a surrogate endpoint is tested jointly with a predictive metric based on the primary endpoint. Secondarily, we explore how the predictive criterion may be strengthened by historical information borrowing, in particular using: (i) historical control data on the primary endpoint, and (ii) the estimated historical relationship between the surrogate and the primary endpoints. We propose various metrics to characterize the risk of correct and incorrect early AAs and demonstrate how the proposed design allows explicit control of these risks, with particular attention to the family‐wise error rate (FWER). The methodology is then evaluated through a simulation study motivated by a Phase‐III trial in metastatic colorectal cancer (mCRC).
JASA Machine Learning Meta-Analysis & Data Integration · 发表于 2026-01-23
Xinyu Tian, Xiaotong Shen
摘要
Reliable machine learning and statistical analysis rely on diverse, well-distributed training data. However, real-world datasets are often limited in size and exhibit underrepresentation across key subpopulations, leading to biased predictions and reduced performance, particularly in supervised tasks such as classification. To address these challenges, we propose Conditional Data Synthesis Augmentation (CoDSA), a novel framework that leverages generative models, such as diffusion models, to synthesize high-fidelity data for improving model performance across multimodal domains, including tabular, textual, and image data. CoDSA generates synthetic samples that faithfully capture the conditional distributions of the original data, with a focus on under-sampled or high-interest regions. Through transfer learning, CoDSA fine-tunes pre-trained generative models to enhance the realism of synthetic data and increase sample density in sparse areas. This process preserves inter-modal relationships, mitigates data imbalance, improves domain adaptation, and boosts generalization. We also introduce a theoretical framework that quantifies the statistical accuracy improvements enabled by CoDSA as a function of synthetic sample volume and targeted region allocation, providing formal guarantees of its effectiveness. Extensive experiments demonstrate that CoDSA consistently outperforms non-adaptive augmentation strategies and state-of-the-art baselines in both supervised and unsupervised settings. *(abstract via PubMed)*
SiM Survival Analysis Machine Learning Networks & Graphs · 发表于 2026-01-22
Xingdong Feng, Qiaoling Li, Xing Qin, Mengyun Wu, Liang Yu
摘要
Accurate prognosis and effective variable selection are essential in high‐dimensional survival analysis, particularly for understanding long‐term survival outcomes. The mixture cure rate model has been commonly adopted for subjects with exceptionally long survival times. However, traditional models usually assume log‐linear effects of covariates, which may not capture the complex and nonlinear relationships in real‐world data. Additionally, clinical observations reveal structural similarity between covariates that influence both patient cure rates and survival times. Existing methods typically estimate the two components of the mixture cure model independently, neglecting their inherent connections. To address these limitations, in this study, we enhance the conventional cure rate model by incorporating deep neural networks with a selection layer, while preserving the similarity structure between the cured and susceptible fractions. By integrating regularization constraints on the selection parameters and weight matrices within the neural network, the proposed approach simultaneously achieves effective variable selection and handles a series of complex nonlinear relationships within the data. To further enhance consistency in variable selection across both components of the cure model, a novel penalty is introduced, enabling the proposed model to identify key variables and enhance overall performance and interpretability in high‐dimensional datasets. Through extensive simulation studies and real‐world data analysis, the superior performance and robustness of the proposed approach are evident.
SiM Causal Inference Missing Data & Measurement Error · 发表于 2026-01-22
Hui Quan, Zhixing Xu, Xun Chen
摘要
For a chronic disease, besides the treatment induction effect, it is also important to demonstrate the maintenance effect of long‐term treatment use. To fulfill these and other objectives for a clinical study, we often apply one of three designs: the active treatment lead‐in followed by randomized maintenance design, the randomized induction followed by re‐randomized withdrawal maintenance design and the treat‐through design (FDA 2022). Separately, a two‐stage sequential parallel comparison design (SPCD) is frequently used in therapeutic areas where placebo has a large effect. In this paper, we use a SPCD for a clinical trial with a binary endpoint for induction, maintenance, long‐term and other treatment effect assessments. This SPCD can actually be treated as a hybrid of the above three designs and has some additional advantages. For example, compared to the re‐randomized withdrawal maintenance design, the SPCD does not need a re‐randomization to simplify trial operation and it also provides controlled data for formal long‐term efficacy and safety analyses. To fully utilize all available data of the two stages for an overall treatment effect evaluation, a weighted combination test is considered with the incorporation of correlations of the components. Further, a multiple imputation approach is applied to handle missing not at random data. Simulations are conducted to evaluate the performances of the methods and a data example is employed to illustrate the applications of the methods.
SiM Clinical Trials · 发表于 2026-01-22
Dong‐Yun Kim, Sung‐Min Han
摘要
Effective monitoring of event rates is essential for maintaining statistical power and study integrity in clinical trials, particularly when the primary endpoint involves time‐to‐event outcomes. We propose Sequential Event Rate Monitoring (SERM), a new and innovative approach for continuous monitoring of event rates. SERM leverages the Sequential Probability Ratio Test (SPRT) with improved boundaries derived from the nonlinear renewal theorem by Kim and Woodroofe (2003). This method represents the first practical implementation of their theoretical work in this area. SERM offers several tangible benefits, including ease of implementation, efficient use of data, and broad applicability to trials. Decision boundaries can be directly obtained from simple formula. A detailed illustration of the method using real‐world data from a large Phase III clinical trial demonstrates its potential for rapid assessment. SERM operates on blinded data so it can be used in tandem with a broad range of study designs while preserving study integrity. Although slow patient accrual lengthens the time needed to reach a conclusion, it does not significantly affect type I or type II errors associated with the decision. This new method provides a robust tool for enhancing trial monitoring, enabling timely and informed decision‐making in diverse clinical settings.
SiM Spatial & Time Series · 发表于 2026-01-22
Li Shandross, Emily Howerton, Lucie Contamin, Harry Hochheiser, Anna Krystalli, Consortium of Infectious Disease Modeling Hubs, Nicholas G. Reich, Evan L. Ray
摘要
Combining predictions from multiple models into an ensemble is a widely used practice across many fields with demonstrated performance benefits. Popularized through domains such as weather forecasting and climate modeling, multi‐model ensembles are becoming increasingly common in public health and biological applications. For example, multi‐model outbreak forecasting provides more accurate and reliable information about the timing and burden of infectious disease outbreaks to public health officials and medical practitioners. Yet, understanding and interpreting multi‐model ensemble results can be difficult, as there are a diversity of methods proposed in the literature with no clear consensus on which is best. Moreover, a lack of standard, easy‐to‐use software implementations impedes the generation of multi‐model ensembles in practice. To address these challenges, we provide an introduction to the statistical foundations of applied probabilistic forecasting, including the role of multi‐model ensembles. We introduce the hubEnsembles package, a flexible framework for ensembling various types of predictions using a range of methods. Finally, we present a tutorial and case‐study of ensemble methods using the hubEnsembles package on a subset of real, publicly available data from the FluSight Forecast Hub.
SiM Genetics & Omics Testing & Uncertainty · 发表于 2026-01-22
Mitra Ebrahimpoor, Renée Menezes, Ningning Xu, Jelle J. Goeman
摘要
Integrated analysis of multi‐omics datasets holds great promise for uncovering complex biological processes. However, the large dimensionality of omics data poses significant interpretability and multiple testing challenges. Simultaneous enrichment analysis (SEA) was introduced to address these issues in single‐omics analysis, providing an in‐built multiple testing correction and enabling simultaneous feature set testing. In this article, we introduce OCEAN, an extension of SEA to multi‐omics data. OCEAN is a flexible approach to analyze potentially all possible two‐way feature sets from any pair of genomics datasets. We also propose two new error rates which are in line with the two‐way structure of the data and facilitate interpretation of the results. The power and utility of OCEAN are demonstrated by analyzing copy number and gene expression data for breast and colon cancer.
SiM Other · 发表于 2026-01-22
Sigrid Leithe, Bjørn Møller, Bjarte Aagnes, Yngvar Nilssen, Paul C. Lambert, Tor Åge Myklebust
摘要
Synthetic patient data has the potential to advance research in the medical field by providing privacy‐preserving access to data resembling sensitive personal data. Assessing the level of privacy offered is essential to ensure privacy compliance, but it is challenging in practice. Many common methods either fail to capture central aspects of privacy or result in excessive caution based on unrealistic worst‐case scenarios. We present a new approach to evaluating the privacy of synthetic datasets from known probability distributions based on the maximal local privacy loss. The strategy is based on measuring individual contributions to the likelihood of generating a specific synthetic dataset, to detect possibilities of reconstructing records in the original data. To demonstrate the method, we generate synthetic time‐to‐event data based on pancreatic and colon cancer data from the Cancer Registry of Norway using sequential regressions including a flexible parametric survival model. This illustrates the method's ability to measure information leakage at an individual level, which can be used to ensure acceptable privacy risks for every patient in the data.
SiM Other · 发表于 2026-01-22
Neve Loewen, Mohammad Jafari Jozani
摘要
This paper introduces a novel methodology for robust regression analysis when traditional mean regression falls short due to the presence of outliers. Unlike conventional approaches that rely on simple random sampling (SRS), our methodology leverages median nomination sampling (MedNS) by utilizing readily available ranking information to obtain training data that more accurately captures the central tendency of the underlying population, thereby enhancing the representativeness of the sample in the presence of extensive outliers in the population. We propose a new loss function that integrates the extra rank information of MedNS data during the training phase of model fitting, thus offering a form of robust regression. Further, we provide an alternative approach that translates the median regression estimation using MedNS to corresponding problems under SRS. Through simulation studies, including a high‐dimensional and a nonlinear regression setting, we evaluate the efficacy of our proposed approach compared to its SRS counterpart by comparing the integrated mean squared error of regression estimates. We observe that our proposed method provides higher relative efficiency (RE) compared to its SRS counterparts. Lastly, the proposed methods are applied to a real data set collected for body fat analysis in adults.
SiM Clinical Trials · 发表于 2026-01-22
Vladimir Dragalin
摘要
For the pharmaceutical industry, the main utility of futility rules is to allow early stopping of a trial when it seems unlikely to achieve its primary efficacy objectives, and it is mainly motivated by financial and ethical considerations. After a brief overview of available approaches in setting a futility rule, I will illustrate, using a case study, different rules based on conditional power, predictive probability of success, and Bayesian predictive probability of success, and will emphasize the main shortcomings that arise when using these measures, especially in sample size re‐estimation designs. I propose, as an alternative, the conditional assurance that is the probability of achieving success at the final analysis when the study was not stopped for futility. It depends on the sample size for the interim, sample size at the final analysis, and the threshold for the futility rule. But it does not need the knowledge of the observed treatment effect estimate at the interim analysis. This makes the conditional assurance very appropriate for building informative futility rules. It balances the probability of stopping for futility (when there is no treatment effect), conditional assurance, and overall power. Decision makers can better understand the levels of risk associated with stopping for futility and make informed decisions about where to spend risk based on what is acceptable to the organization.
SiM Longitudinal Data Survival Analysis · 发表于 2026-01-22
Tsung‐I Lin, Wan‐Lun Wang
摘要
Clustering longitudinal biomarkers in clinical trials uncovers associations between clinical outcomes, disease progression, and treatment effects. Finite mixtures of multivariate linear mixed‐effects (FM‐MtLME) models have proven effective for modeling and clustering multiple longitudinal trajectories that exhibit grouped patterns with strong within‐group similarity. Motivated by an AIDS study with plasma viral loads measured under assay‐specific detection limits, this article extends the FM‐MtLME model to account for censored outcomes. The proposed model is called the FM‐MtLME with censoring (FM‐MtLMEC). To allow covariate‐dependent mixing proportions, we further extend it with a logistic link, resulting in the EFM‐MtLMEC model. Two efficient EM‐based algorithms are developed for parameter estimation of both FM‐MtLMEC and EFM‐MtLMEC models. The utility of our methods is demonstrated through comprehensive analyses of the AIDS data and simulation studies.
SiM Survey & Sampling · 发表于 2026-01-22
Benmei Liu, Hyune‐Ju Kim, Joe Zou, Eric J. Feuer, Barry I. Graubard
摘要
Joinpoint regression can model trends in time‐specific aggregated estimates. These methods have been developed mainly for non‐survey data such as cancer registry data, and only recently have been extended to utilize survey data that accounts for complex sample designs resulting in non‐zero correlation between the time‐specific estimates. This correlation can occur for surveys with data from the same sampled units used across time points, for example, the annual National Health Interview Survey with multistage cluster samples using the same first‐stage sampled clusters over consecutive time points. Another issue when modeling aggregated data is that the degrees of freedom for joinpoint analyses of multistage cluster samples are based on the number of time points, not the number of first‐stage sampled clusters as used in survey methods. To address this, we propose models of individual‐level data that incorporate both the correlation between time points and correct the degrees of freedom due to the sampling design that is needed for accurate inferences. Also, a modified design‐based Akaike Information Criterion (M‐dAIC) for model selection is proposed to account for complex sample designs. These new methods are empirically compared to existing methods using simulation studies and health survey data examples. The simulation studies indicated that this new individual‐level model identified the true number of joinpoints more accurately than the established aggregate‐level models for data collected using complex survey designs with moderate to large interclass correlation coefficients (ICC).
SiM Missing Data & Measurement Error Diagnostics & Prediction Causal Inference · 发表于 2026-01-22,收录于 2026-10-20
Wenze Tang, Donna Spiegelman, Yujie Wu, Molin Wang
摘要
In this paper, we investigate the selection of minimal and efficient covariate adjustment sets for the imputation-based regression calibration method, which corrects for bias due to continuous exposure measurement error. We use directed acyclic graphs to illustrate how subject-matter knowledge aids in selecting these sets. For unbiased measurement error correction, researchers must collect, in both main and validation studies, (I) common causes of both the true exposure and the outcome, and (II) common causes of both measurement error and the outcome. For regression calibration under linear models, at minimum, covariate set (I) must be adjusted for in both the measurement error model (MEM) and the outcome model, while set (II) should be adjusted for in at least the MEM. Adjusting for non-risk factors that are correlates of true exposure or measurement error within the MEM alone improves efficiency. We apply this covariate selection approach to the Health Professionals Follow-up Study, assessing fiber intake's effect on cardiovascular disease. We also highlight potential pitfalls in data-driven MEM building that ignores structural assumptions. Additionally, we extend existing estimators to allow for effect modification. Finally, we caution against using regression calibration to estimate the effect of true nutritional intake through calibrating biomarkers.
SiM Bayesian Methods Spatial & Time Series Survival Analysis · 发表于 2026-01-22
Mingyue Qiu, Lianming Wang, Qingning Zhou, Tao Hu
摘要
The objective of this study is to perform variable selection and parameter estimation for analyzing partly interval‐censored data based on a proportional hazards model that incorporates spatial effects. To broaden the model's applicability across diverse scenarios, we consider two types of spatial structures: adjacency and distance information. Leveraging the differentiable properties of the ‐ball prior developed through projection‐based methods, we have devised an efficient Bayesian algorithm by introducing latent variables and applying stochastic gradient Langevin dynamics principles. This algorithm can rapidly deliver results without resorting to complex sampling steps. Through simulations encompassing various scenarios, we have validated the performance of this method in both variable selection and parameter estimation. In our real data application, the proposed approach selects important variables associated with the emergence time of permanent teeth. Additionally, it identifies the spatial structure that best fits these data characteristics. This selection and identification are based on two Bayesian model selection criteria: the log pseudo‐marginal likelihood and the deviance information criterion.
SiM Bayesian Methods Clinical Trials · 发表于 2026-01-22
Yunyi Liu, Maile Young Karris, Sonia Jain
摘要
Cluster randomized controlled trials where groups (or clusters) of individuals, rather than single individuals, are randomized are especially useful when individual‐level randomization is not feasible or when interventions are naturally delivered at the group level. Balanced randomization in the cluster randomized trial setting can pose logistical challenges and strain resources if subjects are randomized to a non‐optimal arm. We propose a Bayesian response‐adaptive randomization design for cluster randomized controlled trials based on Thompson sampling, which dynamically allocates clusters to the most efficacious treatment arm based on the interim posterior distributions of treatment effects using Markov chain Monte Carlo sampling. Our design also incorporates early stopping rules for efficacy and futility determined by prespecified posterior probability thresholds. The performance of the proposed design is evaluated across various operating characteristics under multiple settings, including varying intra‐cluster correlation coefficients, cluster sizes, and effect sizes. Our adaptive approach is also compared with a standard, parallel two‐arm cluster randomized controlled clinical trial design, highlighting improvements in both ethical considerations and efficiency. From our simulation studies based on an HIV behavioral trial, we demonstrate these improvements by preferentially assigning more clusters to the more efficacious intervention while maintaining robust statistical power and controlling false positive rates.
SiM Bayesian Methods Clinical Trials · 发表于 2026-01-22
Junichi Asano, Hiroyuki Sato, Shin Watanabe, Akihiro Hirakawa
摘要
Platform trials enable the evaluation of multiple investigational drugs for a single disease and offer flexibility in adding or dropping treatments during the trial. This design would be advantageous for reducing the sample size and drug development time, particularly in contexts such as pandemics. In the platform trials, non‐concurrent controls (NCCs) are often used for drug–control comparisons, but temporal shifts in subject characteristics, trial conduct, or standard of care can introduce bias in the estimation of treatment effects and increase the type I error rate. In this study, we develop a new Bayesian power prior to incorporate NCC data in platform trials with binary outcomes. To address temporal shifts, our method adjusts the amount of information borrowed from NCCs using a data‐driven similarity index between NCC and concurrent control (CC) data. This index serves as the power parameter in the power prior, enabling adaptive borrowing. We evaluated the proposed method through extensive simulation studies, comparing its operating characteristics with seven alternatives: analysis using only CC data, naïve pooling method, a frequentist linear regression model, and four Bayesian methods designed to address temporal shifts. Across a range of temporal shift scenarios, the proposed method consistently achieved a favorable balance between type I error control and statistical power, maintaining type I error rates below 10% while avoiding the overborrowing seen in more aggressive methods. The practical utility of the proposed method was also examined by applying it to data from a platform trial involving patients with COVID‐19.
SiM Latent Variables & Mixtures Bayesian Methods · 发表于 2026-01-22
Hwasoo Shin, Marco A. R. Ferreira, Allison N. Tegge
摘要
We present a novel framework for concomitant dimension reduction and clustering. This framework is based on a novel class of Bayesian clustering factor models. These models assume a factor model structure where the vectors of common factors follow a mixture of Gaussian distributions. We develop a Gibbs sampler to explore the posterior distribution and propose an information criterion to select the number of clusters and the number of factors. Simulation studies show that our inferential approach appropriately quantifies uncertainty. In addition, when compared to two previously published competitor methods, our information criterion has favorable performance in terms of correct selection of number of clusters and number of factors. Finally, we illustrate the capabilities of our framework with an application to data on recovery from opioid use disorder where clustering of individuals may facilitate personalized health care.
SiM Clinical Trials · 发表于 2026-01-22
Gosuke Homma, Takuma Yoshida
摘要
To reduce drug development costs and time in therapeutic areas with high unmet medical needs, sponsors are often motivated to accelerate the drug development process, specifically by skipping the Phase 2 trial and starting the Phase 3 trial directly after the Phase 1 trial. To address this need, a novel design called 2‐in‐1 adaptive design has been proposed recently. This design allows a trial to maintain a small trial or to expand to a large trial adaptively based on decisions made based on the interim analysis. Although several statistical methods have been proposed for the 2‐in‐1 adaptive design, they specifically emphasize clinical trials with continuous or time‐to‐event endpoints assuming the normal approximation of the test statistic. Methods for the 2‐in‐1 adaptive design with binary endpoints are notably lacking. For binary endpoints, some statistical tests do not rely on the normal approximation. Therefore, it is not clear whether the operating characteristics obtained by existing 2‐in‐1 adaptive design methods in the context of continuous or time‐to‐event endpoints can be generalized to cases with binary endpoints. For this study, we propose formulas to evaluate the type I error rate and power for the 2‐in‐1 adaptive design for binary endpoints. Our proposed formulas can evaluate the exact type I error rate and power without using Monte Carlo simulations. Moreover, the proposed formulas are useful for any statistical test of binary endpoints. Numerical investigations under different scenarios demonstrated that the operating characteristics for the 2‐in‐1 adaptive design with binary endpoints are similar to those with continuous or time‐to‐event endpoints. We present the application of our proposed formulas to a clinical trial in patients with pyruvate kinase deficiency.
SiM Clinical Trials Bayesian Methods · 发表于 2026-01-22,收录于 2026-08-20
Wanni Lei, Maosen Peng, Nasser K. Altorki, Xi Kathy Zhou
摘要
(verbatim from the bepress preprint, https://biostats.bepress.com/cobra/art122/ — Wiley returned 403. Cornell VIVO lists a publication date of "January 1, 2026," but that system commonly defaults to a start-of-year date, so the precise date is unconfirmed)*: "Phase II clinical trials play a pivotal role in drug development by screening a large number of drug candidates to identify those with promising preliminary efficacy for phase III testing. Trial designs that enable efficient decision-making with small sample sizes and early futility stopping while controlling for type I and II errors in hypothesis testing, such as Simon's two-stage design, are preferred. Randomized multi-arm trials are increasingly used in phase II settings to overcome the limitations associated with using historical controls as the reference. However, how to effectively balance efficiency and accurate decision-making continues to be an important research topic. A notable development in phase II randomized design methodology is the Bayesian pick-the-winner (BPW) design that extends a Simon's two-stage based multi-arm design with a Bayesian winner-selection strategy. Despite multiple appealing features, this method cannot easily control for overall type I and II errors for winner selection. Here, we introduce an improved randomized two-stage Bayesian pick-the-winner (IBPW) design that formalizes the winner-selection based hypothesis testing, optimizes sample sizes and decision cut-offs by strictly controlling the type I and type II errors under a set of flexible hypotheses for winner-selection across two treatment arms. Simulation studies demonstrate that our new design offers improved operating characteristics for winner selection while retaining the desirable features of the BPW design.
SiM Survival Analysis · 发表于 2026-01-22
Yiqi Li, Yuan Huang, Ying Sheng, Qingzhao Zhang
摘要
With the increasing availability of data from different sources, there is a growing interest in leveraging summary information from external studies to improve parameter estimation efficiency for the internal study that collects individual‐level data. However, when analyzing right‐censored survival data, covariate effects often vary across studies due to differences in study environments, research designs, and patients' inclusion criteria. Such heterogeneity, if not accounted for properly, can lead to biased estimates of covariate effects. In this article, we develop a Privacy‐preserving and Heterogeneity‐aware Integration (PHI) method to improve efficiency in estimating regression parameters of the internal Cox model under population heterogeneity. The PHI method characterizes parameter heterogeneity by assuming an unknown cluster structure across datasets, and constructs an augmented log partial likelihood function with a fusion penalty to simultaneously estimate the cluster structure and adaptively incorporate summary statistics from external datasets. Estimation consistency and asymptotic normality are established for the proposed estimator. We further prove that the proposed estimator is asymptotically more efficient than the traditional maximum partial likelihood estimator under mild conditions. The PHI method also achieves consistency in estimating the underlying cluster structure across datasets. Simulation studies and brain tumor data analysis are used to investigate the finite‐sample performance of the proposed method.
SiM High-Dimensional Longitudinal Data · 发表于 2026-01-22
Auriane Gabaut, Rodolphe Thiébaut, Cécile Proust‐Lima, Mélanie Prague
摘要
Non‐linear mixed effects models (NLMEMs) defined by ordinary differential equations (ODEs) are central to modeling complex biological systems over time, particularly in pharmacometrics, viral dynamics, and immunology. However, selecting relevant covariates associated with dynamics in high‐dimensional settings remains a major challenge. This study introduces a novel model‐building approach called Lasso‐SAMBA (SAMBA: Stochastic Approximation for Model Building Algorithm) that integrates Lasso regression with a stability selection algorithm for robust covariate selection within ODE‐based NLMEMs. The method iteratively constructs models by coupling penalized regression with mechanistic model estimation using the SAEM algorithm. It extends a prior strategy named SAMBA, originally based on stepwise inclusion, by replacing this step with a penalized, stability‐driven approach that reduces false discoveries and improves selection robustness. By maintaining the monotonic decrease of the information criterion through a calibrated exploration of penalization parameters, the proposed method outperforms conventional stepwise and Bayesian variable selection alternatives. Extensive simulation studies, spanning pharmacokinetic and immunological models, demonstrate the superiority of Lasso‐SAMBA in variable selection fidelity, FDR (False Discovery Proportion) control, and computational efficiency. The Lasso‐SAMBA method is implemented in an R package. Applied to a Varicella‐Zoster virus vaccination study, the method reveals robust, biologically plausible associations between parameters of the mechanistic model of the humoral immune response and early transcriptomic expressions. These results underscore the practical utility of our method for high‐dimensional model building in systems vaccinology and beyond.
SiM Clinical Trials Testing & Uncertainty · 发表于 2026-01-22
Haidy A. Newer
摘要
Statistical inference in multicenter clinical trials is often compromised when relying on asymptotic normal approximations, particularly in designs characterized by a small number of centers or severe imbalance in patient enrollment. Such deviations from asymptotic assumptions frequently result in unreliable p ‐values and a breakdown of error control. To resolve this, we introduce a high‐precision saddlepoint approximation framework for aggregate permutation tests within hierarchically structured data. The theoretical core of our approach is the derivation of a multilevel nested cumulant generating function that explicitly models the trial hierarchy, analytically integrating patient‐level linear rank statistics with the stochastic aggregation process across centers. A significant innovation of this work is the extension to the bivariate setting to address co‐primary endpoints , providing a robust inferential solution for mixed continuous (efficacy) and discrete (safety) outcomes where standard multivariate normality is unattainable. The resulting framework yields simulation‐free, highly accurate tail probabilities even in finite‐sample regimes. Extensive simulation studies confirm that our method maintains strict Type I error control in scenarios where asymptotic methods exhibit substantial inflation. Furthermore, an application to the multicenter diabetes prevention program trial demonstrates the method's practical utility: it correctly identifies a significant cardiovascular risk factor that standard approximations failed to detect, thereby preventing a critical Type II error and ensuring valid clinical conclusions.
SiM Functional Data · 发表于 2026-01-22
Yvelin Gansou, Karim Oualkacha, Marzia Angela Cremona, Lajmi Lakhal‐Chaieb
摘要
We introduce a test for the overall effect of interaction between DNA methylation and a set of single nucleotide polymorphisms on a quantitative phenotype. The developed inference procedure is based on a functional approach that extend existing regression models in functional data analysis. Through extensive simulations, we show that the proposed test effectively controls type I error rates and highlights increased empirical power over existing methods, particularly when multiple interactions are present. The use of the proposed test is illustrated with an application to data from obesity patients and controls.
SiM Missing Data & Measurement Error Bayesian Methods · 发表于 2026-01-22
Harlan Campbell, Tim P. Morris, Paul Gustafson
摘要
Derived variables are variables that are constructed from one or more source variables through established mathematical operations or algorithms. For example, body mass index (BMI) is a derived variable constructed from two source variables: weight and height. When using a derived variable as the outcome in a statistical model, complications arise when some of the source variables have missing values. In this paper, we propose how one can define a single fully integrated Bayesian model to simultaneously impute missing values and sample from the posterior. We compare our proposed method with alternative approaches that rely on multiple imputation (MI), with examples including an analysis to estimate the risk of microcephaly (a derived variable based on sex, gestational age, and head circumference at birth) in newborns exposed to the ZIKA virus.
SiM Bayesian Methods · 发表于 2026-01-22
Joseph B. Kadane
摘要
Each patient is simultaneously given several binary tests for a disease. The tests are partitioned into disjoint groups, assumed to be conditionally independent between groups, but allowed to have arbitrary dependence within a group. The groups are intended to capture similar biological features of the tests. A Dirichlet‐multinomial model is employed with a Gibbs Sampler to estimate the sensitivity and specificity of the tests. The model is exemplified by data on four tests for Chlamydia, both with complete data and with a random 10% of the data treated as missing.
SiM Survival Analysis Machine Learning Diagnostics & Prediction · 发表于 2026-01-22,收录于 2026-10-02
Zhu et al.
摘要
Deep learning has excelled in the field of statistical learning. In the field of survival analysis, some studies have combined deep learning methods with partially linear structures to propose deep partially linear structures. We extend it to the field of competing risks and propose the deep partially linear subdistribution hazard model (DPLSHM). To evaluate the predictive performance of the model, we further develop a time‐dependent AUC method specifically tailored for competing risks data and provide an estimator for AUC. Theoretical results for the proposed model demonstrate the asymptotic normality of the parameter component at a rate of and provide the convergence rate of the nonparametric component, which achieves the minimal limit convergence rate (multiplicative logarithmic factors). The theory of consistency and rate of convergence of AUC‐related estimates is also developed, while we prove that the regression component of DPLSHM maximizes theoretical AUC asymptotically. Subsequently, the paper validates the excellent performance of DPLSHM in estimation and prediction through numerical simulations and real‐world datasets.
SiM Diagnostics & Prediction Clinical Trials Optimization & Learning Theory · 发表于 2026-01-22
Yingjie Qiu, Yan Han, Beibei Guo
摘要
In immunotherapy, both the dose and the schedule of drug administration can significantly influence therapeutic effects by modulating immune system activation. Incorporating immune response measures into clinical trial designs offers an opportunity to enhance decision‐making by leveraging their close association with therapeutic efficacy and toxicity. Motivated by settings where biomarker data indicate improved efficacy in biomarker‐positive patients, we propose a dose–schedule optimization strategy tailored to each biomarker‐defined subgroup, based on elicited utility functions that capture risk‐benefit tradeoffs. We introduce a joint modeling framework that simultaneously evaluates immune response, toxicity, and efficacy, enabling information sharing across outcome types and patient subgroups. Our approach utilizes parsimonious yet flexible models designed specifically to address challenges due to small sample sizes commonly encountered in early‐phase trials. Simulation studies demonstrate that the proposed design achieves desirable operating characteristics and effectively informs dose–schedule optimization.
SiM Longitudinal Data Survival Analysis Clinical Trials · 发表于 2026-01-22
Yixiu Liu, Depeng Jiang, Mahmoud Torabi, Xuekui Zhang
摘要
Cluster randomized controlled trials (CRCTs) are commonly used when interventions are delivered at the group level. Since data from CTCTs are inherently multilevel, methods that properly account for clustering are required. Joint modeling (JM) of longitudinal and survival data allows for simultaneous evaluation of intervention effects on repeated measures and time‐to‐event outcomes, offering a comprehensive view of intervention effects. However, existing JMs do not accommodate clustered data structures typically of CRCTs. This study introduces a multilevel joint model (MJM) to simultaneously evaluate intervention effects on correlated longitudinal and survival outcomes. The model was applied to empirical data from a large CRCT evaluating the PAX Good Behavior Game, a classroom‐based mental health intervention involving 4189 Grade 1 students across 313 classrooms during the 2011–2012 school year. Mental health was assessed at three time points: pre‐PAX (January 2012), post‐PAX (June 2012), and Grade 5 (June 2016). Time‐to‐first mental disorder diagnosis was tracked through March 2024. Simulation studies further evaluated the MJM's performance under varying conditions, including censoring rates, cluster sizes, group‐level variances, and survival model specifications. Results indicated the PAX program significantly improved mental health trajectories and reduced the risk of mental disorder diagnoses. The MJM outperformed traditional JMs by producing more accurate estimates and standard errors. Both empirical and simulation findings demonstrated that ignoring hierarchical structures leads to biased inferences and underestimation of intervention effects. The proposed MJM offers a robust and flexible analytic framework for analyzing data from CRCTs, emphasizing the importance of accounting for clustering in evaluating group‐based interventions.
Biometrics Spatial & Time Series · 发表于 2026-01-21
Mehdi Moradi, Matthias Eckardt
摘要
Spatial phenomena in environmental and biological contexts often involve events that are unevenly distributed across space, carrying attributes whose associations/variations are space-dependent. In this paper, we introduce the class of inhomogeneous mark correlation functions, which capture mark associations/variations while explicitly accounting for spatial inhomogeneity. The proposed functions quantify how, on average, marks vary or associate with one another as a function of pairwise spatial distances. We develop nonparametric estimators and evaluate their performance through simulation studies, covering a range of scenarios with mark association or variation, spanning from nonstationary point patterns without spatial interaction to patterns with clustering tendencies and sparse regions. Our simulations reveal the shortcomings of traditional methods under spatial inhomogeneity, underscoring the necessity of our approach. The results show that our estimators accurately identify both the positivity/negativity and the effective spatial range for detected mark associations/variations. Furthermore, we show that differences in how intensity is estimated generally have only a negligible influence on the empirical bias/variance of our proposed inhomogeneous mark correlation functions. The proposed inhomogeneous mark correlation functions are then applied to two distinct forest ecosystems: Longleaf pine trees in southern Georgia, USA, marked by their diameter at breast height, and Scots pine trees in Pfynwald, Switzerland, marked by their height. Our findings reveal that the inhomogeneous mark correlation functions provide more detailed insights into tree growth patterns compared to traditional methods.
SMMR High-Dimensional Latent Variables & Mixtures Bayesian Methods · 发表于 2026-01-21
Abdalkarim Alnajjar, Helen Bian, Zihang Lu
摘要
Cluster analysis has been widely used in biomedical studies for disaggregating heterogeneous diseases and identifying disease subtypes that may inform clinical decisions. In the era of advanced data science and engineering, cluster analysis faces new challenges due to high dimensionality, multimodality and computational complexity. In the present study, we propose a fast integrative clustering approach based on variational Bayesian inference, called iClusterVB. The iClusterVB enables the integration of multiple datasets into the clustering process while performing feature selection in high-dimensional settings for mixed data types, including continuous, categorical, and count data. Simulation studies are performed to compare the performance of iClusterVB with six competing methods and highlight its advantages. Additionally, iClusterVB is applied to three real-life studies to demonstrate its utility in identifying important features and cancer subtypes that are associated with distinct survival probabilities. A user-friendly R package iClusterVB and a tutorial are developed to implement the proposed approach.
SMMR Longitudinal Data Latent Variables & Mixtures Bayesian Methods · 发表于 2026-01-20
Asael Fabian Martínez, Ivonne Ramírez-Silva, Ruth Fuentes-García
摘要
The identification of latent profile trajectories in longitudinal studies represents an important challenge for specialists since they could provide insights to better understand their problem of interest. The majority of the statistical methodologies for cluster analysis for longitudinal data are based on growth curve or mixed-effects models, and often incorporate covariates for a better adjustment. In particular, for Bayesian nonparametric methods, Dirichlet process mixture models are widely used together. We propose a clustering methodology for longitudinal data based on mixture models generated by a discrete random probability measure whose weights are decreasingly ordered by construction. Additionally, data is modeled without making use of covariates and assuming independence across time for individual measurements. Our approach also provides a straightforward procedure to merge some estimated groups, since it could happen that there are many of them, to be easily explained by experts. Our results suggest that, at least for a first analysis, this framework is enough to effectively detect groups in the data; further exploration of each group could incorporate extra information. We apply our methodology for detecting adiposity trajectories in Mexican children in a secondary analysis of the “Prenatal Omega-3 fatty acid Supplementation and Child Growth and Development” study (POSGRAD) cohort.
SMMR Survival Analysis Bayesian Methods · 发表于 2026-01-19
Jose A Christen, Francisco J Rubio
摘要
The hazard function is central to the formulation of commonly used survival regression models such as the proportional hazards and accelerated failure time models. However, these models rely on a shared baseline hazard, which, when specified parametrically, can only capture limited shapes. To overcome this limitation, we propose a general class of parametric survival regression models obtained by modelling the hazard function using autonomous systems of ordinary differential equations (ODEs). Covariate information is incorporated via transformed linear predictors on the parameters of the ODE system. Our framework capitalises on the interpretability of parameters in common ODE systems, enabling the identification of covariate values that produce qualitatively distinct hazard shapes associated with different attractors of the system of ODEs. This provides deeper insights into how covariates influence survival dynamics. We develop efficient Bayesian computational tools, including parallelised evaluation of the log-posterior, which facilitates integration with general-purpose Markov Chain Monte Carlo samplers. We also derive conditions for posterior asymptotic normality, enabling fast approximations of the posterior. A central contribution of our work lies in the case studies. We demonstrate the methodology using clinical trial data with crossing survival curves, and a study of cancer recurrence times where our approach reveals how the efficacy of interventions (treatments) on hazard and survival are influenced by patient characteristics.
SMMR Survival Analysis Clinical Trials · 发表于 2026-01-19
Stephanie Pan, Prasad Patil, Janice Weinberg, Sara Lodi, Michael P LaValley
摘要
Generalized pairwise comparison (GPC) methods are extensions of the Mann–Whitney approach that allow comparisons of outcomes through prioritized ranking, and they have been widely applied in randomized controlled trials (RCTs). Importantly, GPC methods can be adapted to handle censored time-to-event data. GPC methods are based on assigning scores to pairs of subjects where all pairs of treatment and control subjects are evaluated: the outcome of each treatment subject is compared with each control subject. The GPC test statistic can be expressed as a treatment effect for the therapeutic intervention by measures such as the net benefit, win odds, win ratio (WR), or probability index. As the focus for this study, the WR has an alternative interpretation as the inverse of the hazard ratio under proportional hazards. However, its estimate could be biased in the presence of substantial censoring. Censoring increases the number of indeterminate treatment and control pairs, where the win or loss is undetermined due to the censored observation(s) and a definitive score cannot be assigned. We propose a novel method leveraging pseudo-observations to address the issue of uninformative pairs resulting from censoring for a time-to-event outcome. We compare the performance of our method with existing GPC methods in simulations under various censoring scenarios. For equal drop-out and administrative censoring, our method provides results that are comparable to existing GPC methods. However, for unequal drop-out, which is common in clinical trials, the performance of our approach relative to existing methods depends on the censoring proportion and distribution. The proposed approach reduced bias and root mean squared error relative to Gehan and Latta under several censoring conditions, but these improvements did not extend to gains in statistical power. Lastly, we illustrate this new GPC approach using two reconstructed RCT datasets.
SMMR Survival Analysis Longitudinal Data Diagnostics & Prediction · 发表于 2026-01-19
Yang-Jin Kim
摘要
A main interest in clinical practice is the prediction of patient prognosis conductive to decision making. Therefore, a relevant prediction model should be able to reflect the updated patient’s condition. A joint model of longitudinal markers and time-to-event data has been widely applied to estimate the association between the risk of the event and the markers’ change. The purpose of this work is to provide dynamic measures for evaluating the predictive accuracy of longitudinal markers in a context of interval-censored failure time data. We propose dynamic area under curve and Brier score reflecting incomplete data structure of interval-censored data. Simulation study compares the prediction performance of joint model and landmarking method. As a real data example, the suggested method is applied to predict the occurrence of dementia using repeatedly measured cognitive scores.
SMMR Testing & Uncertainty · 发表于 2026-01-19
Nikola Štefelová, Javier Palarea-Albaladejo, Josep Antoni Martín-Fernández
摘要
Testing group differences in compositional data, that is, multivariate data referring to parts of a whole, requires focussing on the relative information between components. This is commonly achieved by mapping the data into a sensible logratio coordinate system. Groupings are often defined by an externally given factor but can also emerge from internal features of the data, such as distinct zero patterns, which may reflect an underlaying structure of subpopulations. This work introduces the PERLOG test, a novel non-parametric permutation test to identify significant groupings based on pairwise logratios, the fundamental units of compositional information. The method is suitable for both externally and internally defined groupings. In particular, the case of groups defined according to zero patterns is discussed as a prominent example of the latter. The performance of the proposal as a statistical test and its advantages over conventional multivariate tests are demonstrated through simulation. Real-world applications are illustrated using data from studies on movement behaviours and time-use epidemiology.